Latest LoneStar Heart Inc. Stories
Outcomes of the AUGMENT-HF Trial of Algisyl-LVR for Advanced Heart Failure Patients Presented at American Heart Association's Clinical Science Special Reports CHICAGO, Nov.
Implantable Gel May Revolutionize the Treatment of Patients Who Lose the Ability to Pump Blood Efficiently to the Body LAGUNA HILLS, Calif., Oct.
Six-month Outcomes of AUGMENT-HF Multicenter Study to Be Presented by Yearend LAGUNA HILLS, Calif., May 5, 2014 /PRNewswire/ --
- A political dynamiter.